Early anticoagulation

DRUG3 trials

Sponsors

National Institute of Cardiology, Warsaw, Poland, Capital Medical University

Conditions

AnticoagulationAtrial FibrillationIschemic StrokeMitral Regurgitation

Phase 4

Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

Enrolling by invitationNCT05305612

National Institute of Cardiology, Warsaw, PolandAnticoagulation, Atrial Fibrillation, Mitral Regurgitation

Start: 2022-03-13End: 2027-03-01Target: 410Updated: 2026-09-17

Unknown Phase

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation

RecruitingNCT07139301

Capital Medical UniversityAtrial Fibrillation, Ischemic Stroke

Start: 2025-09-04End: 2026-08-31Target: 438Updated: 2026-08-05

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

RecruitingNCT07139314

Capital Medical UniversityAtrial Fibrillation, Ischemic Stroke

Start: 2025-09-24End: 2026-11-30Target: 240Updated: 2026-09-15

Related Papers

Timing of anticoagulation after emergency endovascular therapy for acute ischaemic stroke with atrial fibrillation (TIMERS): protocol for a randomised controlled trial.

2026-09-09

Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial.

2024-02-222 citations